Mar 26, 2024, 07:03 ET Up to 3.3% Placebo-Adjusted Mean Weight Loss (5.3% from Baseline) Observed After 28 Days VK2735 Shown to be Safe and Well-Tolerated in 28-Day Study with Low Rates of GI-Related Adverse Events Phase 2 Trial in Obesity Planned for 2H24 Conference Call Scheduled for 8:00 a.m
People often report a gradual reduction in body fat percentage, an improved metabolism, and higher energy levels
Like any medical treatment, GLP-1 medications can have side effects most commonly mild nausea, which typically improves as your body adjusts
Nature 455 , 674678 (2008)
Cycle Most community protocols run 8 to 12 weeks on, then 4 weeks off
PharmaTher PharmaTher is a Canadian specialty pharmaceutical company focused on developing psychedelic and peptide-based therapies